Todd Rosengart, M.D., MBA, FACS

Picture

Todd Rosengart, M.D., MBA, FACS

Professor and Chair, Department of Surgery

Request Clinical Appointment

Positions

Professor and Chair, Department of Surgery: Baylor College of Medicine

DeBakey-Bard Chair of Surgery: Baylor College of Medicine

Professor of Molecular & Cellular Biology: Baylor College of Medicine

Vice President, Hospital Operations and Quality Improvement: Baylor College of Medicine

Professor of Heart and Vascular Disease: Texas Heart Institute

Addresses

Baylor St. Luke’s Medical Center (Clinic)
: THI Outpatient Clinic
1101 Bates Avenue
Houston, TX 77030
United States
Phone: (713) 798-1300

Education

Clinical Fellowship at The New York Hospital: New York; Thoracic Surgery

Research Fellowship at National Institutes of Health: 01/1987 - Bethesda, MD United States

Residency at New York University Medical Center: 01/1989 - New York, New York United States; General Surgery

Internship at New York University Medical Center: 01/1985 - New York, NY United States; General Surgery

MD from Northwestern University: 01/1983 - Chicago, IL United States

Certifications

Board Certified: American Board of Surgery

Board Certified: American Board of Thoracic Surgery

Honors & Awards

Texas “Super Doctor”: Texas Monthly

Top Doctors: 2013 – 2020; Houstonian Magazine

Top Doctors: 2004-2006; Chicago Magazine

Top Doctors: 2007-2012; New York Magazine

America’s Top Doctors: 3rd – 11th Edition; Castle Connolly

Distinguished Scientist Award: 2017; Baylor St. Luke’s Medical Center

Professional Interests

Cardiothoracic Surgery
Off-pump Surgery
Coronary Artery Bypass Surgery
Minimally invasive Aortic or Mitral Repair or Replacement

Professional Statement

Dr. Todd K. Rosengart, professor and chair of the Michael E. DeBakey Department of Surgery and DeBakey-Bard Chair of Surgery, is also professor of heart and vascular disease at the Texas Heart Institute and professor of molecular and cell biology at Baylor. He is an NIH-funded scientist with uninterrupted extramural funding since 1998. He is past president of the Society of Surgical Chairs, representing the academic chairs of surgery in North America, and is a member of the board of directors of the American Association for Thoracic Surgery, the world’s oldest society for cardiothoracic surgery.

In 1997, Dr. Rosengart and his team at Cornell performed the world’s first viral-based cardiac gene transfer procedure, part of a landmark NIH and FDA-approved angiogenesis trial for “no option” patients with end stage coronary artery disease. He is PI of a cardiovascular surgery NIH T32 training grant, recipient of over $20 million in total research grants, holds fourteen issued U.S. patents (three additional patents pending) and is author of over 200 peer-reviewed articles and other publications with over 13,500 citations and an h-index of 62 (Google Scholar). He has mentored nearly 100 research and cardiac surgery trainees.

Dr. Rosengart is past chair of the NIH Bioengineering, Technology and Surgical Sciences Study Section, chair of the American College of Surgeons National Surgeon Scientist Study Section, member of the Leducq Foundation Scientific Advisory Committee and a member of the American College of Surgeons Academy of Master Surgeon Educators. He is past editor of Seminars in Thoracic and Cardiovascular Surgery, serving since 2013. Amongst other affiliations, he is a member of the American Surgical Association and a fellow of the American College of Cardiology.

Dr. Rosengart’s institutional roles include his serving as two-term chair of the BCM Faculty Group Practice Board of Governors and as a member of the Baylor St. Luke’s Medical Center Board of Directors. He previously served as board chair of the Affiliated Medical Services, a 1000-member consortium of BCM and University of Texas faculty staffing the Harris Health county medical system, one of the largest in the US. He also previously served as national chair of the cardiac surgery service line for CHI (now Common Spirit), a 140-hospital not-for-profit organization with 40 cardiac surgery programs, the largest not-for-profit hospital system in the US.

Dr. Rosengart is co-founder of Vitals.com (MDx, LLC, which before its recent acquisition had become one of the world’s largest web-based medical consumerism companies. He is also co-founder of XyloCor Therapeutics, a $60 million gene therapy startup which recently successfully completed enrollment in an FDA Fast Track designated Phase 2 national trial of a “next-gen” angiogenic gene therapy for treating patients with end stage coronary artery disease.